Pure Global AI
NMRA National

National Pharmacovigilance Guidelines, November 2023

National Pharmacovigilance Guidelines
SomaliaMinistry of Health and Human Services / National Medicines Regulatory AuthorityVigilance
Official source linked
What this code is

National Pharmacovigilance Guidelines, November 2023 is the official NMRA identifier for “National Pharmacovigilance Guidelines”. National Pharmacovigilance Guidelines, November 2023 is the official identifier NMRA uses for this instrument.

Instrument
National
Full name
National Pharmacovigilance Guidelines, November 2023
Category
Vigilance
Source links
Source publication
English
Open the source text
Linked source text; confirm the publisher, publication details and any later amendment or consolidated version.
Readable HTML
1 language version
Read the full text →
Direct citations can link to a specific article or section by appending its fragment identifier.
Dates
Published
—
Effective
—
Readable full text

Open a language version

Each version has stable passage anchors for direct citations and highlighting. The readable text is generated from an authority source and does not replace the legally controlling publication.

English full textEnglish — original textRead HTML →
About this regulation

National Pharmacovigilance Guidelines

Complete 41-page Ministry-hosted national guideline. Its scope includes medical devices; section 4.9 addresses adverse events following the use of medical devices and the criteria for reporting. This vigilance source is not presented as a general device marketing-authorisation regulation.

National Pharmacovigilance Guidelines, November 2023 is the official identifier NMRA uses for this instrument. Always confirm the current consolidated text and transition provisions with the official source before filing.

Source linked